INTERIM REPORT
JANUARY 1 – MARCH 31, 2025

Margin improvement continues, the debt level is reduced, and acquisition activity increases

The margins improved in both business areas in line with our priorities and initiatives. The debt level continued to decrease, and we have achieved our ambition to lower the net debt in relation to EBITDA to below 3.0. AddLife is now ready to gradually increase acquisition activity, and at the beginning of April, the acquisition of Edge Medical was completed.

Fredrik Dalborg, President and CEO

FIRST QUARTER

  • Net sales increased by 5 percent to SEK 2,702m (2,570). The organic growth, excluding exchange rate changes, was 4 percent and the acquired growth was 1 percent. 
  • EBITA increased by 18 percent to SEK 343m (291), corresponding to an EBITA margin of 12.7 percent (11.3). 
  • Profit after tax amounted to SEK 120m (63).
  • Earnings per share amounted to SEK 0.98 (0.52). Earnings per share for the last 12 months amounted to SEK 2.53 (0.65).
  • Cash flow from operating activities amounted to SEK 240m (97).
  • The equity ratio was 41 percent (41).
  • Return on working capital (P/WC) amounted to 53 percent (51).
  • After the end of the quarter, an acquisition has been completed, Edge Medical Ltd., UK.
 		  
  Q1 Q1 ∆ Apr 2024- Full year
SEKm 2025 2024 % Mar 2025 2024
Net sales 2,702 2,570 5 10,418 10,286
EBITA 343 291 18 1,211 1,159
EBITA margin, % 12.7 11.3   11.6 11.3
Profit/loss before taxes 172 100 72 477 405
Profit for the period 120 63 90 311 254
Earnings per share (EPS), before/after dilution, SEK 0.98 0.52 88 2.53 2.06
Dynamisk graf: Net sales (SEKm)
Dynamisk graf: EBITA (SEKm)

 

Latest updated: 4/24/2025 3:57:04 PM by Johanna Prim
NEXT